SLC26A4
Pendrin
Also known as: DFNB4, PDS, S26A4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43511
- Gene
- SLC26A4
- Ensembl
- ENSG00000091137
- Chromosome
- 7
- Canonical length
- 780 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
780 residues, UniProt reviewed canonical sequence.
>O43511|SLC26A4
1 MAAPGGRSEP PQLPEYSCSY MVSRPVYSEL AFQQQHERRL QERKTLRESL AKCCSCSRKR
61 AFGVLKTLVP ILEWLPKYRV KEWLLSDVIS GVSTGLVATL QGMAYALLAA VPVGYGLYSA
121 FFPILTYFIF GTSRHISVGP FPVVSLMVGS VVLSMAPDEH FLVSSSNGTV LNTTMIDTAA
181 RDTARVLIAS ALTLLVGIIQ LIFGGLQIGF IVRYLADPLV GGFTTAAAFQ VLVSQLKIVL
241 NVSTKNYNGV LSIIYTLVEI FQNIGDTNLA DFTAGLLTIV VCMAVKELND RFRHKIPVPI
301 PIEVIVTIIA TAISYGANLE KNYNAGIVKS IPRGFLPPEL PPVSLFSEML AASFSIAVVA
361 YAIAVSVGKV YATKYDYTID GNQEFIAFGI SNIFSGFFSC FVATTALSRT AVQESTGGKT
421 QVAGIISAAI VMIAILALGK LLEPLQKSVL AAVVIANLKG MFMQLCDIPR LWRQNKIDAV
481 IWVFTCIVSI ILGLDLGLLA GLIFGLLTVV LRVQFPSWNG LGSIPSTDIY KSTKNYKNIE
541 EPQGVKILRF SSPIFYGNVD GFKKCIKSTV GFDAIRVYNK RLKALRKIQK LIKSGQLRAT
601 KNGIISDAVS TNNAFEPDED IEDLEELDIP TKEIEIQVDW NSELPVKVNV PKVPIHSLVL
661 DCGAISFLDV VGVRSLRVIV KEFQRIDVNV YFASLQDYVI EKLEQCGFFD DNIRKDTFFL
721 TVHDAILYLQ NQVKSQEGQG SILETITLIQ DCKDTLELIE TELTEEELDV QDEAMRTLASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC26A4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 247 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 247 nTPM
- cerebral cortex: 8.6 nTPM
- kidney: 6 nTPM
- parathyroid gland: 3.7 nTPM
- prostate: 3.6 nTPM
- urinary bladder: 1.4 nTPM
Single-cell type
- renal collecting duct intercalated cells: 443 nCPM
- endometrial secretory cells: 104 nCPM
- prostatic club cells: 58 nCPM
- prostatic glandular cells: 31 nCPM
- retinal pigment epithelial cells: 30 nCPM
- other brain neurons: 25 nCPM
Immune cell
- naive B-cell: 1 nTPM
- T-reg: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 48 nTPM
- basal ganglia: 36 nTPM
- amygdala: 20 nTPM
- hippocampal formation: 18 nTPM
- white matter: 16 nTPM
- hypothalamus: 8.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC26A4.
Disease | AllUniProt
Conditions SLC26A4 is implicated in, by any mechanism.
- Pendred syndrome (PDS) MIM:274600
- Deafness, autosomal recessive, 4 (DFNB4) MIM:600791
Disease | GeneticClinVar
635 pathogenic / likely-pathogenic of 1,813 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 4
- Pendred syndrome
- Rare genetic deafness
- SLC26A4-related disorder
- Hearing loss, autosomal recessive
Disease | AutoantibodyPubMed
Conditions in which antibodies against SLC26A4 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for SLC26A4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases.
2009 · J Clin Endocrinol Metab · RCR 0.8 · 28 citations - Low frequency of pendrin autoantibodies detected using a radioligand binding assay in patients with autoimmune thyroid disease.
2013 · J Clin Endocrinol Metab · RCR 0.2 · 6 citations - Absence of anti-pendrin auto-antibodies in the sera of Tunisian patients with autoimmune thyroid diseases.
2010 · Clin Lab · RCR 0.1 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.01
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chloride transmembrane transport
- inorganic anion transport
- iodide transport
- monoatomic ion transport
- regulation of pH
- regulation of protein localization
- sensory perception of sound
- sulfate transmembrane transport
Molecular functions
- chloride transmembrane transporter activity
- chloride:bicarbonate antiporter activity
- iodide transmembrane transporter activity
- oxalate transmembrane transporter activity
- secondary active sulfate transmembrane transporter activity
- sulfate transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC26A4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC26A4 as an antibody target. Whether an autoantibody or antibody against SLC26A4 could matter depends on whether native SLC26A4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC26A4 is annotated at the cell surface, where native SLC26A4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC26A4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...